Maike Buchner

2.2k total citations · 1 hit paper
35 papers, 1.3k citations indexed

About

Maike Buchner is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Maike Buchner has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Genetics and 16 papers in Immunology. Recurrent topics in Maike Buchner's work include Chronic Lymphocytic Leukemia Research (18 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Maike Buchner is often cited by papers focused on Chronic Lymphocytic Leukemia Research (18 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Maike Buchner collaborates with scholars based in Germany, United States and United Kingdom. Maike Buchner's co-authors include Katja Zirlik, Hassan Jumaa, Hendrik Veelken, Markus Müschen, Meike Burger, Gabriele Prinz, Christine Dierks, Thomas Wossning, Fabian Köhler and Michael Bach and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Maike Buchner

33 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling

2012 379 citations Marcus Dühren-von Minden, Rudolf Übelhart et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maike Buchner Germany	17	649	546	452	439	269	35	1.3k
Erin Hertlein United States	20	768 1.2×	551 1.0×	774 1.7×	517 1.2×	271 1.0×	48	1.7k
Lugui Qiu China	17	236 0.4×	222 0.4×	483 1.1×	183 0.4×	397 1.5×	125	1.0k
Jonathan H. Schatz United States	18	199 0.3×	494 0.9×	614 1.4×	413 0.9×	96 0.4×	74	1.5k
Ningjing Lin China	15	362 0.6×	285 0.5×	457 1.0×	407 0.9×	54 0.2×	66	1.4k
Ingo Ringshausen Germany	21	611 0.9×	335 0.6×	1.0k 2.3×	387 0.9×	194 0.7×	47	1.8k
Eva Hellqvist Sweden	9	243 0.4×	497 0.9×	313 0.7×	157 0.4×	68 0.3×	14	964
Shao Ning Yang United States	17	213 0.3×	451 0.8×	816 1.8×	380 0.9×	118 0.4×	26	1.5k
Asumi Yokota Japan	25	375 0.6×	323 0.6×	817 1.8×	79 0.2×	539 2.0×	61	1.8k
Susanne Hipp Germany	15	378 0.6×	298 0.5×	717 1.6×	220 0.5×	207 0.8×	22	1.2k
Nadja Zaborsky Austria	18	256 0.4×	386 0.7×	283 0.6×	138 0.3×	102 0.4×	49	945

Countries citing papers authored by Maike Buchner

Since Specialization

Citations

This map shows the geographic impact of Maike Buchner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maike Buchner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maike Buchner more than expected).

Fields of papers citing papers by Maike Buchner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maike Buchner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maike Buchner. The network helps show where Maike Buchner may publish in the future.

Co-authorship network of co-authors of Maike Buchner

This figure shows the co-authorship network connecting the top 25 collaborators of Maike Buchner. A scholar is included among the top collaborators of Maike Buchner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maike Buchner. Maike Buchner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Steiger, Katja, et al.. (2025). Autoimmunity promotes chronic lymphocytic leukemia progression in an indolent disease model. Scientific Reports. 15(1). 4117–4117.

Iyer, Prajish, Bo Zhang, Tingting Liu, et al.. (2024). MGA deletion leads to Richter’s transformation by modulating mitochondrial OXPHOS. Science Translational Medicine. 16(758). eadg7915–eadg7915. 5 indexed citations

Buchner, Maike. (2024). Insights into PI3K / AKT signaling in B cell development and chronic lymphocytic leukemia. FEBS Letters. 599(20). 2896–2910. 2 indexed citations

Lee, Hye‐Kyung, Manuela A. Hoechstetter, Maike Buchner, et al.. (2023). Analysis of immune responses in patients with CLL after heterologous COVID-19 vaccination. Blood Advances. 7(10). 2214–2227. 8 indexed citations

Ecker, Veronika, Piero Giansanti, Aida Varela-Moreira, et al.. (2023). Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progression. Cell Reports. 42(10). 113017–113017. 7 indexed citations

Varela-Moreira, Aida, Daniëlle Krijgsman, Veronika Ecker, et al.. (2022). Utilizing in vitro drug release assays to predict in vivo drug retention in micelles. International Journal of Pharmaceutics. 618. 121638–121638. 25 indexed citations

Ecker, Veronika, Thomas Engleitner, Ingo Ringshausen, et al.. (2021). Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia. Nature Communications. 12(1). 3526–3526. 50 indexed citations

Park, Eugene, A. P. Moore, Antonella Santoro, et al.. (2020). Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance. Science Translational Medicine. 12(526). 22 indexed citations

Ecker, Veronika, Martina Braun, Wilko Weichert, et al.. (2020). Pathological RANK signaling in B cells drives autoimmunity and chronic lymphocytic leukemia. The Journal of Experimental Medicine. 218(2). 15 indexed citations

10.

Varela-Moreira, Aida, Veronika Ecker, Sanjay N. Mandhane, et al.. (2018). Nanomedicines for the treatment of hematological malignancies. Journal of Controlled Release. 287. 194–215. 107 indexed citations

11.

Buchner, Maike, Rainer Claus, Kathrin Kläsener, et al.. (2016). Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia. PLoS ONE. 11(12). e0169159–e0169159. 13 indexed citations

12.

Shojaee, Seyedmehdi, Lai N. Chan, Maike Buchner, et al.. (2016). PTEN opposes negative selection and enables oncogenic transformation of pre-B cells. Nature Medicine. 22(4). 379–387. 83 indexed citations

13.

Buchner, Maike, Eugene Park, Huimin Geng, et al.. (2015). Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia. Nature Communications. 6(1). 6471–6471. 39 indexed citations

14.

Buchner, Maike & Markus Müschen. (2014). Targeting the B-cell receptor signaling pathway in B lymphoid malignancies. Current Opinion in Hematology. 21(4). 341–349. 31 indexed citations

15.

Buchner, Maike, Huimin Geng, Srividya Swaminathan, et al.. (2014). The Linker Protein GAS7 Negatively Regulates Pre-B Cell Differentiation and Amplifies Proliferation and Survival Signals in Acute Lymphoblastic Leukemia. Blood. 124(21). 3777–3777. 1 indexed citations

16.

Leonhardt, Franziska, Katja Zirlik, Maike Buchner, et al.. (2012). Spleen tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels. Leukemia. 26(7). 1617–1629. 31 indexed citations

17.

Minden, Marcus Dühren-von, Rudolf Übelhart, Thomas Wossning, et al.. (2012). Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature. 489(7415). 309–312. 379 indexed citations breakdown →

18.

Stachon, Peter, Anna Missiou, Nerea Varo, et al.. (2010). Tumor Necrosis Factor Receptor Associated Factor 6 Is Not Required for Atherogenesis in Mice and Does Not Associate with Atherosclerosis in Humans. PLoS ONE. 5(7). e11589–e11589. 19 indexed citations

19.

Buchner, Maike, Natalie Stickel, Gabriele Prinz, et al.. (2010). The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia – CXCR4 antagonists as potential adjuvants for monoclonal antibodies. British Journal of Haematology. 151(2). 167–178. 25 indexed citations

20.

Warncke, Max, Maike Buchner, Anna Dodero, et al.. (2010). Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cells. Cancer Immunology Immunotherapy. 60(1). 49–60. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact